Letters to the Editor Open access

Comments on “Clinical, radiological and histopathological profile of patients with endobronchial lesions on fibreoptic bronchoscopy” by Sarma et al.

Authors

Published
23 November 2022
Section
Letters to the Editor
DOI
10.4081/monaldi.2022.2467

Abstract

Dear Editor,

The article by Sharma et al. regarding endobronchial biopsy in 120 patients in northern India is an attempt to understand the clinical profile, etiology and pathology of the patients who presented with endobronchial findings. The article concluded that most of the population was middle-aged males with non-small cell carcinoma being the most common diagnosis. However, there are few important points to ponder and understand in the study.

Keywords

References

  1. Sharma D, Kandhuri R, Raghuvanshi S, et al. Clinical, radiological and histopathological profile of patients with endobronchial lesions on fibreoptic bronchoscopy. Monaldi Arch Chest Dis 2022:2312. DOI: https://doi.org/10.4081/monaldi.2022.2312
  2. Muthu V, Ram B, Sehgal IS, et al. Predictors of severe bleeding during endobronchial biopsy: Experience of 537 cases. J Bronchology Interv Pulmonol 2019;26:273-9. DOI: https://doi.org/10.1097/LBR.0000000000000593
  3. Carr IM, Koegelenberg CF, von Groote-Bidlingmaier F, et al. Blood loss during flexible bronchoscopy: a prospective observational study. Respiration 2012;84:312-8. DOI: https://doi.org/10.1159/000339507
  4. Gupta AA, Sehgal IS, Dhooria S, et al. Indications for performing flexible bronchoscopy: trends over 34 years at a tertiary care hospital. Lung India 2015;32:211-5. DOI: https://doi.org/10.4103/0970-2113.156213
  5. Pedro C, Melo N, Novais E Bastos H, et al. Role of bronchoscopic techniques in the diagnosis of thoracic sarcoidosis. J Clin Med 2019;8:1327. DOI: https://doi.org/10.3390/jcm8091327

Metrics

Citations and online attention from Dimensions, Altmetric and PlumX.

PlumX Metrics

License

Copyright (c) 2022 The Author(s)

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.